Risk of renal cell carcinoma after kidney transplantation

V. Kliem,M. Kolditz,M. Behrend,G. Ehlerding,R. Pichlmayr,K. M. Koch,R. Brunkhorst
DOI: https://doi.org/10.1111/j.1399-0012.1997.tb00815.x
1997-08-01
Clinical Transplantation
Abstract:Abstract Between December 1968 and July 1995, 2372 renal transplant recipients were seen regularly in our outpatient clinic. 154 patients (6.5%) of these subsequently developed a malignant tumor. One of the most frequently observed malignancies was a renal cell carcinoma in the native kidneys, found in 12 patients (7.8%; i.e. 0.5% of the total population), two of them with analgesic nephropathy and one with adult polycystic kidney disease. So‐called acquired cystic kidney disease of the native kidneys was found in 73% of the patients with renal cell carcinoma. In the patients with renal cell carcinoma the median age at transplantation was 43.9 (39–55) yr. The median time from onset of end‐stage renal failure and from transplantation to the appearance of the tumor amounted to 117.3 (43–206) and 75.8 (5–164) months, respectively. Despite nephrectomy, four patients died of the cancer (6–57 months). As a consequence we suggest a regular sonographic screening of the native kidneys twice a year in all renal transplant patients. As in dialysis patients, the main risk factors for the development of renal cell carcinoma seem to be so‐called acquired cystic disease of the native kidneys and the underlying renal disease, such as analgesic nephropathy, and obviously not the immunosuppressive regimen after transplantation.
surgery,transplantation
What problem does this paper attempt to address?